Centagen is developing Reprogramming Biologics (RB^TM) to epigenetically reprogram cells in humans and mammals. To solve the problems of aging and disease, our patent-pending RB therapeutics will enable the safe reprogramming of older adult cells into more functional young cells. The RB engineered nano particles can operate safely both in vitro and in vivo to reprogram specific tissues and organs, or the whole body.